Design-functionality relationships for adhesion/growth-regulatory galectins.
Medrano, Francisco J
FitzGerald, Forrest G
Hasley, William D
Kostina, Nina Yu
Klein, Michael L
MetadataShow full item record
JournalProceedings of the National Academy of Sciences of the United States of America
AbstractGlycan-lectin recognition is assumed to elicit its broad range of (patho)physiological functions via a combination of specific contact formation with generation of complexes of distinct signal-triggering topology on biomembranes. Faced with the challenge to understand why evolution has led to three particular modes of modular architecture for adhesion/growth-regulatory galectins in vertebrates, here we introduce protein engineering to enable design switches. The impact of changes is measured in assays on cell growth and on bridging fully synthetic nanovesicles (glycodendrimersomes) with a chemically programmable surface. Using the example of homodimeric galectin-1 and monomeric galectin-3, the mutual design conversion caused qualitative differences, i.e., from bridging effector to antagonist/from antagonist to growth inhibitor and vice versa. In addition to attaining proof-of-principle evidence for the hypothesis that chimera-type galectin-3 design makes functional antagonism possible, we underscore the value of versatile surface programming with a derivative of the pan-galectin ligand lactose. Aggregation assays with N,N'-diacetyllactosamine establishing a parasite-like surface signature revealed marked selectivity among the family of galectins and bridging potency of homodimers. These findings provide fundamental insights into design-functionality relationships of galectins. Moreover, our strategy generates the tools to identify biofunctional lattice formation on biomembranes and galectin-reagents with therapeutic potential.
- Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.
- Authors: Rauthu SR, Shiao TC, André S, Miller MC, Madej É, Mayo KH, Gabius HJ, Roy R
- Issue date: 2015 Jan 2
- Adhesion/growth-regulatory galectins tested in combination: evidence for formation of hybrids as heterodimers.
- Authors: Miller MC, Ludwig AK, Wichapong K, Kaltner H, Kopitz J, Gabius HJ, Mayo KH
- Issue date: 2018 Mar 15
- How altering the modular architecture affects aspects of lectin activity: case study on human galectin-1.
- Authors: Kutzner TJ, Gabba A, FitzGerald FG, Shilova NV, García Caballero G, Ludwig AK, Manning JC, Knospe C, Kaltner H, Sinowatz F, Murphy PV, Cudic M, Bovin NV, Gabius HJ
- Issue date: 2019 Jul 19
- Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins.
- Authors: André S, Sansone F, Kaltner H, Casnati A, Kopitz J, Gabius HJ, Ungaro R
- Issue date: 2008 Jul 2
- Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
- Authors: André S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius HJ
- Issue date: 1999 Aug-Sep